National Institute on Drug Abuse; Notice of Meeting, 2697-2698 [2011-727]
Download as PDF
<![CDATA[
2697
Federal Register / Vol. 76, No. 10 / Friday, January 14, 2011 / Notices
1985),’’ New England Journal of
Medicine, 319:1557–62, 1988.
10. Nourjah P. et al, ‘‘Estimates of
Acetaminophen (Paracetamol)-induced
Overdoses in the United States,’’
Pharacoepidemiological Drug Safety, 6:
406–409, 2006.
11. Lai, M.W. et al., ‘‘2005 Annual Report
of the American Association of Poison
Control Centers’ National Poisoning and
Exposure Database,’’ Clinical Toxicology,
44:803–932, 2006.
Dated: January 10, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011–709 Filed 1–13–11; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Proposed Project: Children’s Hospitals
Graduate Medical Education Payment
Program (CHGME Payment Program)
(OMB No. 0915–0247)—[Revision]
Health Resources and Services
Administration
Agency Information Collection
Activities: Proposed Collection:
Comment Request
In compliance with the requirement
for opportunity for public comment on
proposed data collection projects
(section 3506(c)(2)(A) of Title 44, United
States Code, as amended by the
Paperwork Reduction Act of 1995, Pub.
L. 104–13), the Health Resources and
Services Administration (HRSA)
publishes periodic summaries of
proposed projects being developed for
submission to the Office of Management
and Budget (OMB) under the Paperwork
Reduction Act of 1995. To request more
information on the proposed project or
to obtain a copy of the data collection
Responses per
respondent
expenses associated with the treatment
of more severely ill patients and the
additional costs relating to teaching
residents in such programs. The
CHGME Payment Program application
forms received OMB clearance on June
30, 2010. Centers for Medicare and
Medicaid Services (CMS) final rule
regarding Sections 5503, 5504, 5505 and
5506 of the Affordable Care Act of 2010,
Public Law 111–148, published in the
Federal Register on Wednesday,
November 24, 2010, requires some
modification of the data collection
within the CHGME Payment Program
application. The CHGME Payment
Program application forms have been
adjusted to accommodate CMS policy
and require OMB approval.
Data are collected on the number of
full-time equivalent residents in
applicant children’s hospitals’ training
programs to determine the amount of
direct and indirect medical education
payments to be distributed to
participating children’s hospitals.
Indirect medical education payments
will also be derived from a formula that
requires the reporting of discharges,
beds, and case mix index information
from participating children’s hospitals.
Hospitals will be requested to submit
such information in an annual
application. Hospitals will also be
requested to submit data on the number
of full-time equivalent residents a
second time during the federal fiscal
year to participate in the reconciliation
payment process.
The estimated annual burden is as
follows:
Total number of
responses
Hours per
response
Total burden
hours
(Initial Application) .....................
(Reconciliation Application) .......
(Initial Application) .....................
(Reconciliation Application) .......
(Initial Application) .....................
(Reconciliation Application) .......
(Reconciliation Application) .......
(Initial Application) .....................
(Reconciliation Application) .......
60
60
60
60
60
60
60
60
60
1
1
1
1
1
1
1
1
1
60
60
60
60
60
60
60
60
60
26.5
6.5
11.33
3.67
0.5
0.5
12.5
.33
.33
1,590
390
679.8
220.2
30
30
750
19.8
19.8
Total ........................................................
mstockstill on DSKH9S0YB1PROD with NOTICES
99–1
99–1
99–2
99–2
99–3
99–3
99–4
99–5
99–5
The CHGME Payment Program was
enacted by Public Law 106–129 and
reauthorized by Public Law 109–307 to
provide federal support for graduate
medical education (GME) to
freestanding children’s hospitals. This
legislation attempts to provide support
for GME comparable to the level of
Medicare GME support received by
other, non-children’s hospitals. The
legislation indicates that eligible
children’s hospitals will receive
payments for both direct and indirect
medical education. Direct payments are
designed to offset the expenses
associated with operating approved
graduate medical residency training
programs and indirect payments are
designed to compensate hospitals for
Number of
respondents
Form
HRSA
HRSA
HRSA
HRSA
HRSA
HRSA
HRSA
HRSA
HRSA
plans and draft instruments, e-mail
paperwork@hrsa.gov or call the HRSA
Reports Clearance Officer on (301) 443–
1129.
Comments are invited on: (a) The
proposed collection of information for
the proper performance of the functions
of the Agency; (b) the accuracy of the
Agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology.
60
............................
60
..............................
3729.6
E-mail comments to
paperwork@hrsa.gov or mail them to the
HRSA Reports Clearance Officer, Room
10–33, Parklawn Building, 5600 Fishers
Lane, Rockville, MD 20857. Written
comments should be received within 60
days of this notice.
Dated: January 10, 2011.
Robert Hendricks,
Director, Division of Policy and Information
Coordination.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2011–713 Filed 1–13–11; 8:45 am]
National Institute on Drug Abuse;
Notice of Meeting
BILLING CODE 4165–15–P
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
VerDate Mar<15>2010
17:03 Jan 13, 2011
Jkt 223001
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
E:\FR\FM\14JAN1.SGM
14JAN1
2698
Federal Register / Vol. 76, No. 10 / Friday, January 14, 2011 / Notices
mstockstill on DSKH9S0YB1PROD with NOTICES
hereby given of a meeting of the
National Advisory Council on Drug
Abuse.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council on Drug Abuse.
Date: February 2, 2011.
Closed: 8:30 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Conference Rooms C & D,
Rockville, MD 20852.
Open: 12 p.m. to 2:45 p.m.
Agenda: This portion of the meeting will
be open to the public for announcements and
reports of administrative, legislative and
program developments in the drug abuse
field.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Conference Rooms C & D,
Rockville, MD 20852.
Contact Person: Teresa Levitin, PhD,
Director, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 4243, MSC 9550, 6001
Executive Boulevard, Bethesda, MD 20892–
89550, (301) 443–2755, tlevitin.nida.nih.gov.
Any member of the public interested in
presenting oral comments to the committee
may notify the Contact Person listed on this
notice at least 10 days in advance of the
meeting. Interested individuals and
representatives of organizations may submit
a letter of intent, a brief description of the
organization represented, and a short
description of the oral presentation. Only one
representative of an organization may be
allowed to present oral comments and if
accepted by the committee, presentations
may be limited to five minutes. Both printed
and electronic copies are requested for the
record. In addition, any interested person
may file written comments with the
committee by forwarding their statement to
the Contact Person listed on this notice. The
statement should include the name, address,
telephone number and when applicable, the
business or professional affiliation of the
interested person.
VerDate Mar<15>2010
17:03 Jan 13, 2011
Jkt 223001
Information is also available on the
Institute’s/Center’s home page: https://
www.drugabuse.gov/NACDA/
NACDAHome.html, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: January 10, 2011.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–727 Filed 1–13–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995, concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer at 240–276–
1243.
Comments are invited on (a) whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Proposed Project: Disaster Technical
Assistance Center Disaster Mental
Health Needs Assessment and Customer
Satisfaction Survey Supporting
Statement—NEW
SAMHSA created the SAMHSA
Disaster Technical Assistance Center
(SAMHSA DTAC) in 2002. SAMHSA
DTAC provides technical assistance
(TA) to States, Territories, and Federally
recognized tribes (hereafter referred to
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
as ‘States’), as well as any behavioral
health worker, in response to, and in
preparation for, behavioral health
(mental health and substance abuse)
needs associated with catastrophic
events and emergencies, such as natural
disasters, bioterrorism, mass criminal
victimization, and environmental
disasters. In the aftermath of a disaster
or other traumatic event, State and local
behavioral health agencies can contact
SAMHSA DTAC for assistance with the
resulting mental health and substance
abuse needs. SAMHSA DTAC TA
specialists respond by identifying
suitable publications and other
materials, arranging for the deployment
of expert consultants, or coordinating
other support services. For
Presidentially declared disasters,
SAMHSA DTAC assists States that are
eligible for a Crisis Counseling
Assistance and Training Program (CCP)
grant by providing TA related to
completing applications, developing a
plan of services, and identifying staff
needs for the CCP.
SAMHSA is proposing two new data
collection efforts: The Disaster
Behavioral Health Needs Assessment
(DBHNA) and the Customer Satisfaction
Survey. The DBHNA will assess the
current gaps and needs at the State and
local provider levels in disaster
behavioral health (DBH) planning and
response efforts. The Customer
Satisfaction Survey is being conducted
to ensure that the TA SAMHSA DTAC
provides is on track, applicable, useful,
and well received. Both of these
proposed data collection efforts will
provide feedback on the ongoing needs
at the national, State, and local levels
and identify areas in which State and
local providers require enhanced TA
services.
SAMHSA DTAC will be responsible
for administering the two data
collection instruments and analyzing
the data. SAMHSA DTAC will use data
from both instruments to inform current
and future TA activities and to ensure
these activities continue to align with
State and local needs.
The components of the data collection
are listed and described below, and a
summary table of the number of
respondents and respondent burden has
also been included.
Disaster Behavior Health Needs
Assessment. The DBHNA will assist
SAMHSA DTAC in identifying
jurisdictions that need assistance with
integrating behavioral health (which
includes both mental health and
substance abuse services) into their
preparedness plans. SAMHSA DTAC
will use the DBHNA to identify gaps
and trends in crisis counseling planning
E:\FR\FM\14JAN1.SGM
14JAN1
]]>Agencies
[Federal Register Volume 76, Number 10 (Friday, January 14, 2011)]
[Notices]
[Pages 2697-2698]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-727]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
[[Page 2698]]
hereby given of a meeting of the National Advisory Council on Drug
Abuse.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council on Drug Abuse.
Date: February 2, 2011.
Closed: 8:30 a.m. to 12 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Conference Rooms C & D, Rockville, MD 20852.
Open: 12 p.m. to 2:45 p.m.
Agenda: This portion of the meeting will be open to the public
for announcements and reports of administrative, legislative and
program developments in the drug abuse field.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Conference Rooms C & D, Rockville, MD 20852.
Contact Person: Teresa Levitin, PhD, Director, Office of
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS,
Room 4243, MSC 9550, 6001 Executive Boulevard, Bethesda, MD 20892-
89550, (301) 443-2755, tlevitin.nida.nih.gov.
Any member of the public interested in presenting oral comments
to the committee may notify the Contact Person listed on this notice
at least 10 days in advance of the meeting. Interested individuals
and representatives of organizations may submit a letter of intent,
a brief description of the organization represented, and a short
description of the oral presentation. Only one representative of an
organization may be allowed to present oral comments and if accepted
by the committee, presentations may be limited to five minutes. Both
printed and electronic copies are requested for the record. In
addition, any interested person may file written comments with the
committee by forwarding their statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: https://www.drugabuse.gov/NACDA/NACDAHome.html, where an agenda
and any additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug
Abuse and Addiction Research Programs, National Institutes of
Health, HHS)
Dated: January 10, 2011.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-727 Filed 1-13-11; 8:45 am]
BILLING CODE 4140-01-P
